Adjuvant Development
Adjuvant Development is the systematic research and design of immunological enhancers that modulate and potentiate the body's adaptive immune response to vaccine antigens, distinguishing it from other vaccine components by its specific role in improving immunogenicity and vaccine efficacy.
1.7K
Publications
87.3K
Citations
9.2K
Authors
1.8K
Institutions
Publications per year
2017–2026
468
Parents
1.7K
Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants
Mark Roman, Elena Martín‐Orozco, Justin S. Goodman et al. · Nature Medicine · 1997 · 916 citations
Liposomes as immunological adjuvants
A. C. Allison, Gregory Gregoriadis · Nature · 1974 · 672 citations
1–5 of 1.7K
9.2K
26
h-index
20
h-index
20
h-index
Infectious Disease Research Institute, United States
23 publications · 1.7K citations
18
h-index
17
h-index
1–5 of 9.2K
1.8K

Infectious Disease Research Institute
Seattle, United States
30 h-index
238 publications
21.9K citations
National Institutes of Health
Bethesda, United States
26 h-index
167 publications
13.9K citations
Harvard University
Cambridge, United States
26 h-index
125 publications
9.3K citations
Statens Serum Institut
Copenhagen, Denmark
25 h-index
123 publications
13.2K citations
The University of Osaka
Osaka, Japan
24 h-index
161 publications
10.9K citations
University of Washington
Seattle, United States
21 h-index
91 publications
3.7K citations
National Institute of Allergy and Infectious Diseases
Bethesda, United States
20 h-index
119 publications
11.8K citations
Purdue University West Lafayette
West Lafayette, United States
18 h-index
68 publications
6.1K citations
1–8 of 1.8K
369 publications · 19.8K citations
74
h-index
53 publications · 3.1K citations
31
h-index
Repository · 76 publications · 3.2K citations
31
h-index
JI · 38 publications · 3.8K citations
27
h-index
47 publications · 1.4K citations
24
h-index
1–5